Osaic Holdings
HOWL icon

Osaic Holdings’s Werewolf Therapeutics HOWL Stock Holding History

Osaic Holdings’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.1K Hold
8,625
– – ﹤0.01% 7126
2026
Q1 		$7.16K Hold
8,625
– – ﹤0.01% 6487
2025
Q4 		$5.43K Sell
8,625
-1,000
-10% -$1.22K ﹤0.01% 6666
2025
Q3 		$13.3K Hold
9,625
– – ﹤0.01% 6190
2025
Q2 		$10.5K Hold
9,625
– – ﹤0.01% 6119
2025
Q1 		$9.34K Buy
9,625
+1,050
+12% +$1.38K ﹤0.01% 5822
2024
Q4 		$12.7K Buy
+8,575
New +$17.5K ﹤0.01% 5631

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.25M AUM 26.51% 1-Year Est. Return
VA
Verdad Advisers Boston, Massachusetts $104M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Osaic Holdings's HOWL Position: Q2 2026 in Review

Osaic Holdings held its Werewolf Therapeutics (HOWL) position steady in Q2 2026 at 8,625 shares worth $3.1K. The position accounts for ﹤0.01% of the portfolio, ranked #7126.

Osaic Holdings first reported a position in HOWL in Q4 2024 and has held it in 7 quarters since. The position peaked at $13.3K in Q3 2025. 45 funds tracked by Wall St. Rank hold HOWL as of Q2 2026.

  • Osaic Holdings held 8,625 shares of Werewolf Therapeutics worth $3.1K as of Q2 2026.
  • Osaic Holdings left its Werewolf Therapeutics share count unchanged in Q2 2026.
  • Werewolf Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7126 holding.
  • Osaic Holdings first reported a position in Werewolf Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Osaic Holdings's Werewolf Therapeutics position peaked at $13.3K in Q3 2025.
  • 45 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.